Dimensional Fund Advisors’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
APM
RCM
FFM
VCM
OCA
TCM
Dimensional Fund Advisors's DNTH Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Dianthus Therapeutics (DNTH) stake by 54% in Q1 2026, buying an estimated $6.65M and bringing the position to 325,440 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #1824.
Dimensional Fund Advisors first reported a position in DNTH in Q1 2020 and has held it in 18 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.
- Dimensional Fund Advisors held 325,440 shares of Dianthus Therapeutics worth $27.3M as of Q1 2026.
- Dimensional Fund Advisors bought 114,767 Dianthus Therapeutics shares in Q1 2026, an estimated $6.65M.
- Dianthus Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1824 holding.
- Dimensional Fund Advisors first reported a position in Dianthus Therapeutics in Q1 2020 and has held it in 18 quarters since.
- 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.